The faculty is made up of a combination of AI specialists, professionals, sand researchers in health systems transformation, teachers in the field, organizations and institutions, and private and public partners, who will contribute to the development of the content of the various activities.
Dr. Fabrice Brunet
Born in France, Dr. Brunet has worked in the field of health and social services for over 30 years. He has been President and Chief Executive Officer of the Centre hospitalier de l’Université de Montréal (CHUM) since September 2015. Previously, he was President and Chief Executive Officer of CHU Sainte-Justine from January 2009 to September 2018 and CEO of both hospitals from September 2015 to 2018. On July 14, 2018, he was made a Knight of the Legion of Honour by France in recognition of his long career in the health field.
He has excellent leadership, initiative, and experience to meet future challenges, as well as to innovate for the benefit of patients through healthcare, teaching, research, and institutional administration activities.
His main research interests include hospital management and health systems integration, artificial intelligence, communication and medical information technologies, continuous improvement of the quality of care and patient safety, international collaboration, and knowledge transfer.
In his career, Dr. Brunet has been a clinical professor in the Department of Pediatrics at the Université de Montréal, a professor of resuscitation in France and of medicine at the University of Toronto, and head of the Department of Resuscitation and Intensive Care and medical director of the Telemedicine Program at St. Michael’s Hospital in Toronto. Since February 2017, he has also been president of the Réseau universitaire intégré de santé de l’Université de Montréal (RUIS), after serving as its vice-president since 2009.
His many achievements include the construction of a clinical research program in intensive care and a cardiac surgery centre in Paris, a hospital project in St. Petersburg, Russia, and the creation of a university centre for resuscitation and intensive care in Toronto. Several modernization projects have been carried out under his direction, including the construction of a new research centre and a building housing specialized care units at CHU Sainte-Justine with a budget of $1.5 billion, and a new CHUM campus with a budget of $3.5 billion.
Dr. Michaël Chassé
Dr. Michaël Chassé is a specialist in intensive care medicine at the Centre hospitalier de l’Université de Montréal (CHUM) and a researcher at the CHUM Research Centre. He holds a PhD in epidemiology from the University of Ottawa and has completed specialized training programs at the Centre for Transfusion Research, as well as in research on safety and quality of care from the University of Ottawa. Dr. Chassé is the scientific director of the Centre d’intégration et d’analyse des données médicales du CHUM (CITADEL), a group of scientists and professionals specialized in data sciences, biostatistics, bioinformatics, and hospital data mining. His main interests are related to using large databases for research and to improving traditional epidemiological research methods using new technologies such as machine learning and innovative clinical trials, particularly in the areas of organ donation and transplantation, blood transfusions, and critical care.
After studying finance and applied economics, François-Xavier Devailly developed a holistic understanding of the decision-making process while obtaining a master’s degree in strategy, then a master’s degree in business intelligence. It was ultimately in pursuing a doctorate in artificial intelligence that he saw the best opportunity to continue his exploration of decision science and to contribute in that area. Mr. Devailly worked in innovation strategy, then in artificial intelligence research and development at Desjardins Group. He has also held management positions in action research projects at the junction of innovation management and data science for the Quebec aerospace cluster. Finally, Mr. Devailly regularly trains volunteers and is involved in several charitable initiatives. Among other things, he is co-founder and co-chair of the IBA Challenge, an international business analytics competition that supports international non-profit organizations in using the data at their disposal.
Dr. Luigi Lepanto
Dr. Luigi Lepanto is Director of Professional Services in the Medical and University Affairs Division of the Centre hospitalier de l’Université de Montréal (CHUM). He is also a clinical full professor in the Department of Radiology, Radiation Oncology, and Nuclear Medicine at the Faculty of Medicine of the Université de Montréal. He has a secondary affiliation with the Department of Health Management, Evaluation, and Policy at the École de santé publique de l’Université de Montréal (ESPUM), where he directs the master’s program in health technology assessment. Dr. Lepanto’s work is focused on the impact on the healthcare pathway of new diagnostic and therapeutic technologies, on the application of information technologies to health, as well as on complex interventions in which the implementation of technologies is combined with the introduction of process changes in care delivery. He favours an approach grounded in assessing and analyzing data emanating from healthcare settings to foster innovation and facilitate its integration into the health system.
Dr. Vincent Poitout
Dr. Vincent Poitout obtained his doctorate in veterinary medicine from the École nationale vétérinaire d’Alfort and his doctorate in Life Sciences from Université Paris 6. He then completed his postdoctoral fellowship at the University of Minnesota, Minneapolis, MN, under the supervision of Dr. Paul Robertson. Dr. Poitout is Professor of Medicine and Director of Research at the Centre hospitalier de l’Université de Montréal (CHUM). Dr. Poitout has chaired both the peer review committee of the American Diabetes Association and the National Research Council of Diabetes Canada. He has been a member of the board of directors of the American Diabetes Association. He is a member of the editorial boards of Diabetes and the Journal of Biological Chemistry, and an associate editor for Diabetologia.
Dr. Poitout’s research is funded by the U.S. National Institutes of Health, the Canadian Institutes of Health Research, and the Natural Sciences and Engineering Research Council of Canada. Dr. Poitout has received several awards, including the Thomas R. Lee Career Development Award from the American Diabetes Association and the Young Investigator Award from the Canadian Diabetes Association. He has published more than 100 scientific articles and reviews. Dr. Poitout holds the Canada Research Chair in Diabetes and Pancreatic Beta-cell Function and is a member of the Canadian Academy of Health Sciences.
Dre Marie-Pascale Pomey
Dr. Marie-Pascale Pomey is a physician specializing in public health; she holds a PhD in public health from the Université de Montréal and Université de Paris 7. She is a professor in the Department of Health Management, Evaluation, and Policy at the École de santé publique de l’Université de Montréal (ESPUM), where she directs the master’s in health administration option on quality and safety management in partnership with patients, users, and families, called QUÉOPSI. She is a researcher at the innovation hub of the Centre de recherche du Centre hospitalier universitaire de Montréal (CRCHUM) and holds the CHUM Chair in the evaluation of advanced technologies and practices; her work focuses on patient engagement at all levels of health system governance. Her research interests include assessing the contribution of new electronic and mobile health technologies that are changing the relationship between health professionals and patients. She is co-director of the Centre of Excellence on Partnership with Patients and the Public, where she is in charge of setting up learning networks. She is also a physician advisor at the Institut national d’excellence en santé et services sociaux (INESSS)
Johan Saba studied economics and finance at McGill University and worked in the financial sector in wealth management at the institutional level. His interest in the quantitative aspect of finance prompted him to pursue a master’s degree at HEC Montréal in business intelligence, which then led him to join a new research and development team in artificial intelligence at the Caisse de dépôt et placement du Québec. However, Mr. Saba observed that data science and artificial intelligence were slow to be adopted in the economy and in society. He therefore co-created SEED AI to democratize artificial intelligence and help organizations of all sizes and maturities use it to generate value.